First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources Toronto, ON, July 28, 2011– Janssen Inc. announced today that after a priority review, Health Canada has
Year: 2012
New Medication to Reduce Bone Complications Now Available in Ontario
Patients with advanced prostate cancer gain access to first-in-class treatment OTTAWA, April 25, 2012 /CNW/ – Canadian Cancer Survivor Network (CCSN) is today congratulating the Ontario government for providing access to XGEVA® (denosumab) for
Participate in Ontario Budget Hearings!
As you know, the government did not hold pre-budget hearings as is normally the case, even though it was planning an extremely harsh budget that will result in major health care cuts. These
Participate in survey on workplace absenteeism and health conditions
Fred Ashbury of Piceps Consultants is working with some colleagues at the University of Wollongong (Australia) on an international research project to design and implement an online survey. The survey focuses on
Ontario men gain access to new medication to reduce bone complications from prostate cancer
Ontario men with advanced prostate cancer now have access to an innovative treatment, XGEVA® (denosumab), for the prevention of debilitating bone complications, such as broken bones, spinal cord compression, or the need
Women`s Health Contribution Program Slashed
Another federal ministry announces program closure – the end of the Women’s Health Contribution Program One more women’s programfalls victim to federal government budget cuts; 16-year program provided essential evidence and information